Advertisement

Topics

Sofinnova Partners Announces DNA Script’ Successful Series A Fundraising of €11 M to Advance Development of Its DNA Synthesis Technology

16:55 EDT 12 Sep 2017 | Biotech-Finances

Tuesday, September 12th 2017 at 6:00am UTC PARIS–(BUSINESS WIRE)– Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, today announced that portfolio company DNA Script, an industry leader in the manufacture of de novo synthetic nucleic acids using proprietary enzymatic technology, has raised €11 million. Sofinnova Partners is DNA Script’s historic and …

Cet article Sofinnova Partners Announces DNA Script’ Successful Series A
Fundraising of €11 M to Advance Development of Its DNA Synthesis
Technology
est apparu en premier sur EEI-BIOTECHFINANCES.

Original Article: Sofinnova Partners Announces DNA Script’ Successful Series A Fundraising of €11 M to Advance Development of Its DNA Synthesis Technology

NEXT ARTICLE

More From BioPortfolio on "Sofinnova Partners Announces DNA Script’ Successful Series A Fundraising of €11 M to Advance Development of Its DNA Synthesis Technology"

Quick Search
Advertisement
 

Relevant Topic

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...